Therefore, we set out to collect a panel of HER2-amplified cancer cell lines across tissue types to begin to determine whether the pathophysiology of HER2-amplified cancers is similar to breast cancers in other tumor types or whether there are significant differences. Here, ERBB2 is linked to breast cancer.